Exhaled Nitric Oxide in Obstructive Sleep Apnea: Compartment-Specific Associations and Incremental Predictive Value
Open Access
- 1 January 2026
- journal article
- Published by China Engineering Science Press Co. Ltd.
Abstract
Background: Airway inflammation is implicated in obstructive sleep apnea (OSA), but nitric oxide signals from different respiratory compartments may provide distinct information. We examined compartment-specific exhaled nitric oxide (eNO) profiles and whether eNO improved OSA prediction beyond routine clinical and anthropometric characteristics. Methods: This prospective cross-sectional study included 965 participants who underwent polysomnography and measurement of fractional exhaled nitric oxide at 50 mL/s (FeNO50), alveolar nitric oxide concentration (CaNO), and fractional nasal nitric oxide at 10 mL/s (FnNO10). Base models were compared with FeNO50-augmented and complete-eNO-panel models using seven classification algorithms and repeated stratified nested cross-validation. Discrimination, calibration, class-specific performance, and clinical net benefit were evaluated for OSA and sleep-related hypoxemia.Results: Of the 965 participants, 798 had OSA and 167 did not. FeNO50 was higher in participants with OSA (median, 21.00 [interquartile range, 16.00–29.00] vs. 18.00 [13.00–23.00] ppb; p < 0.001). CaNO showed a modest between-group difference, whereas FnNO10 did not differ between groups. FeNO50 was elevated across OSA severity categories without a clear dose–response gradient. It was not correlated with apnea-hypopnea index (AHI) and showed only a very weak inverse correlation with nadir oxygen saturation, while remaining independently associated with OSA after multivariable adjustment. Adding FeNO50 resulted in small, nonsignificant changes in area under the receiver operating characteristic curve (ROC-AUC) for OSA (ΔAUC, −0.009 to 0.009) and hypoxemia (ΔAUC, −0.009 to 0.002). The complete eNO-panel models achieved ROC-AUCs of 0.769–0.839 for OSA and 0.788–0.820 for hypoxemia.Conclusions: FeNO50 captures an airway inflammatory phenotype associated with OSA but does not closely reflect polysomnographic severity. Its incremental predictive contribution beyond established clinical and anthropometric characteristics was limited, supporting its use as complementary phenotypic information rather than a stand-alone OSA screening test.Keywords
This publication has 28 references indexed in Scilit:
- Evaluating Prediction Models of Sleep Apnea From Smartphone-Recorded Sleep Breathing SoundsJAMA Otolaryngology–Head & Neck Surgery, 2022
- Diagnosis and Management of Obstructive Sleep ApneaJAMA, 2020
- A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction modelsJournal of Clinical Epidemiology, 2019
- Measurement of fractional exhaled nitric oxide and nasal nitric oxide in male patients with obstructive sleep apneaSleep and Breathing, 2018
- A calibration hierarchy for risk models was defined: from utopia to empirical dataJournal of Clinical Epidemiology, 2016
- Increased alveolar nitric oxide concentration is related to nocturnal oxygen desaturation in obstructive sleep apnoeaNitric Oxide, 2015
- Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8Translational Research, 2010
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure–induced airway hyperresponsivenessJournal of Allergy and Clinical Immunology, 2007
- Airway inflammation in patients affected by obstructive sleep apnea syndromeRespiratory Medicine, 2004